Results 261 to 270 of about 512,272 (346)

Pre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling   +36 more
wiley   +1 more source

Acute Viral Hepatitis

open access: yesJournal of the Royal College of Physicians of London, 1981
openaire   +3 more sources

Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.
Mònica Ortega Llobet   +10 more
wiley   +1 more source

Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation. [PDF]

open access: yesViruses
Cabezas J   +8 more
europepmc   +1 more source

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy